Management of osteoporosis

Por Lewiecki, E Michael
Publicado em 2004

Denosumab: an investigational drug for the management of postmenopausal osteoporosis

Por Lewiecki, E Michael
Publicado em 2008

Lasofoxifene for the prevention and treatment of postmenopausal osteoporosis

Por Lewiecki, E Michael
Publicado em 2009

Intravenous zoledronic acid for the treatment of osteoporosis: The evidence of its therapeutic effect

Por Lewiecki, E Michael
Publicado em 2010

Safety and tolerability of denosumab for the treatment of postmenopausal osteoporosis

Por Lewiecki, E Michael
Publicado em 2011

Denosumab in Postmenopausal Osteoporosis: What the Clinician Needs to Know

Por Lewiecki, E. Michael
Publicado em 2009

Bisphosphonates for the treatment of osteoporosis: insights for clinicians

Por Lewiecki, E. Michael
Publicado em 2010

Preventing Fractures in Diabetic Dialysis Patients

Por Lewiecki, E. Michael
Publicado em 2012

Role of sclerostin in bone and cartilage and its potential as a therapeutic target in bone diseases

Por Lewiecki, E. Michael
Publicado em 2014

New and emerging concepts in the use of denosumab for the treatment of osteoporosis

Por Lewiecki, E. Michael
Publicado no Ther Adv Musculoskelet Dis (2018)

Vitamin D and COVID-19: Is something better than nothing?

Por Lewiecki, E. Michael
Publicado no Osteoporos Sarcopenia (2020)

Romosozumab, clinical trials, and real-world care of patients with osteoporosis

Por Lewiecki, E. Michael
Publicado no Ann Transl Med (2020)

COVID-19, Medical Education, and Bone Health: Insights From Project ECHO

Por Lewiecki, E. Michael, Rothman, Micol S.
Publicado no J Clin Densitom (2020)

Suicide, Guns, and Public Policy

Por Lewiecki, E. Michael, Miller, Sara A.
Publicado em 2013

Common mistakes in the clinical use of bone mineral density testing

Por Lewiecki, E Michael, Lane, Nancy E
Publicado em 2008

Beeper Bite: A Jogging Complication in Physicians

Por Lewiecki, E. Michael, Mason, William van H.
Publicado em 1982

Denosumab for the Treatment of Osteoporosis

Por Zaheer, Sarah, LeBoff, Meryl, Lewiecki, E. Michael
Publicado no Expert Opin Drug Metab Toxicol (2015)

Sclerostin inhibition: a novel therapeutic approach in the treatment of osteoporosis

Por Shah, Arti D, Shoback, Dolores, Lewiecki, E Michael
Publicado no Int J Womens Health (2015)

Challenges in osteoporosis awareness and management: results from a survey of US postmenopausal women

Por Lewiecki, E. Michael, Leader, Deane, Weiss, Richard, Williams, Setareh A.
Publicado no J Drug Assess (2019)

Presentation of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Third International Workshop

Por Silverberg, Shonni J., Lewiecki, E. Michael, Mosekilde, Leif, Peacock, Munro, Rubin, Mishaela R.
Publicado no J Clin Endocrinol Metab (2009)